SCHEMBL11965792

SCHEMBL11965792

CC(=O)/C=C/c1c(C)c(C)c(C)c(C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
ALDH1A1 P00352 5/20 0.42
MAPT P10636 4/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
LMNA P02545 2/20 0.39
IAPP P10997 2/20 0.38
PTGS1 P23219 1/20 0.38
HTT P42858 2/20 0.35
KDM4E B2RXH2 2/20 0.35
GAA P10253 2/20 0.35
SMN1; SMN2 Q16637 3/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2C19 P33261 1/20 0.33
APP P05067 2/20 0.32
ALK Q9UM73 1/20 0.32
NPC1 O15118 1/20 0.31
ABCC4 O15439 1/20 0.30
NR1I2 O75469 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31501088 0.79 ALDH1A1 (0.48) ALDH1A1MAPTLMNAPTGS1HTT
SCHEMBL13164787 0.79 ALDH1A1 (0.48) ALDH1A1MAPTLMNAPTGS1HTT
SCHEMBL8074415 0.77 MAPT (0.33) GLATDP1ALDH1A1MAPTMEN1
SCHEMBL8074416 0.77 MAPT (0.33) GLATDP1ALDH1A1MAPTMEN1
SCHEMBL18662485 0.76 ALDH1A1 (0.50) ALDH1A1MAPTLMNAPTGS1HTT
SCHEMBL18662483 0.76 ALDH1A1 (0.50) ALDH1A1MAPTLMNAPTGS1HTT
SCHEMBL14302972 0.75 IAPP (0.44) GLATDP1ALDH1A1MAPTMEN1
SCHEMBL6049312 0.75 GLA (0.45) GLATDP1ALDH1A1MAPTMEN1
SCHEMBL6049311 0.75 GLA (0.45) GLATDP1ALDH1A1MAPTMEN1
SCHEMBL10792668 0.73 MAPT (0.33) ALDH1A1MAPTMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130029923-A1 Materials and Methods for Prevention and Treatment of Viral Infections BAGI RESEARCH LIMITED (CN) 2013-01-31 US disclosed
US-8242171-B2 Method for reducing the weight of a subject or inhibiting weight gain in a subject PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-08-14 US disclosed
US-7879951-B2 Organic insulator composition, organic insulating layer including the composition, and organic thin film transistor including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2011-02-01 US disclosed
US-20100316679-A1 COMPOSITIONS FOR TREATING OR PREVENTING OBESITY AND INSULIN RESISTANCE DISORDERS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-12-16 US disclosed
US-20100242139-A1 XENOHORMESIS BASED COMPOSITIONS AND METHODS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-09-23 US disclosed
US-7741508-B2 Single step green process for the preparation of substituted cinnamic esters with trans-selectivity COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2010-06-22 US disclosed
US-20100035885-A1 COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2010-02-11 US disclosed
US-20090206330-A1 Organic insulator composition, organic insulating layer including the composition, and organic thin film transistor including the same SAMSUNG ELECTRONICS CO., LTD. 2009-08-20 US disclosed
US-20080045742-A1 Single step green process for the preparation of substituted cinnamic esters with trans-selectivity COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130029923-A1 Materials and Methods for Prevention and Treatment of Viral Infections ZC3HAV1, ZC3HAV1L, ZYX GLA 716/4885TDP1 3945/4885ALDH1A1 2925/4885
US-20100035885-A1 COMPOSITIONS FOR MANIPULATING THE LIFESPAN AND STRESS RESPONSE OF CELLS AND ORGANISMS SIRT1, SIRT2, FOXO3 GLA 247/4885TDP1 281/4885ALDH1A1 4264/4885
US-20100316679-A1 COMPOSITIONS FOR TREATING OR PREVENTING OBESITY AND INSULIN RESISTANCE DISORDERS FABP4, GPR119, SIRT1 GLA 481/4885TDP1 4683/4885ALDH1A1 1973/4885
US-20080045742-A1 Single step green process for the preparation of substituted cinnamic esters with trans-selectivity ADH5, CYP2E1, ADH1A GLA 802/4885TDP1 2786/4885ALDH1A1 52/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.